Escolar Documentos
Profissional Documentos
Cultura Documentos
Neisseria gonorrhoeae
Neisseria gonorrhoeae causes gonorrhea, a sexually transmitted disease that can
result in discharge and inflammation at the urethra, cervix, pharynx, or rectum.
Multidrug-Resistant Acinetobacter
Acinetobacter is a type of gram-negative bacteria that is a cause of
pneumonia or bloodstream infections among critically ill patients. Many of
these bacteria have become very resistant to antibiotics.
Drug-Resistant Campylobacter
Campylobacter usually causes diarrhea (often bloody), fever, and abdominal
cramps, and sometimes causes serious complications such as temporary
paralysis.
Fluconazole-Resistant Candida
Candidiasis is a fungal infection caused by yeasts of the genus Candida. There are
more than 20 species of Candida yeasts that can cause infection in humans, the most
common of which is Candida albicans. Candida yeasts normally live on the skin and
mucous membranes without causing infection. However, overgrowth of these
microorganisms can cause symptoms to develop. Symptoms of candidiasis vary
depending on the area of the body that is infected.
Candida is the fourth most common cause of healthcare-associated bloodstream
infections in the United States. In some hospitals it is the most common cause. These
infections tend to occur in the sickest patients.
Drug-Resistant Shigella
Shigella usually causes diarrhea (sometimes bloody), fever, and abdominal
pain. Sometimes it causes serious complications such as reactive
arthritis. High-risk groups include young children, people with inadequate
handwashing and hygiene habits, and men who have sex with men.
Drug-Resistant Tuberculosis
Tuberculosis (TB) is among the most common infectious diseases and a
frequent cause of death worldwide. TB is caused by the bacteria
Mycbacterium tuberculosis (M. tuberculosis) and is spread mostly through
the air. M. tuberculosis can affect any part of the body, but disease is found
most often in the lungs. In most cases, TB is treatable and curable with the
available first-line TB drugs; however, in some cases, M. tuberculosis can be
resistant to one or more of the drugs used to treat it. Drug-resistant TB is
more challenging to treat it can be complex and requires more time and
more expensive drugs that often have more side effects. Extensively drugresistant TB (XDR TB) is resistant to most TB drugs; therefore the patients are
left with treatment options that are much less effective. The major factors
driving TB drug resistance are incomplete or wrong treatment, short drug
supply, and lack of new drugs. In the United States most drug-resistant TB is
found among persons born outside of the country.
- - 2
23000 .
.
2016 -
46
-2 , VAP-1, - -3 ,
-7, 1, -1
.
VRE
MRSA
2015
119
2016
73
CRE
Pseudomonas
Acinetobacteria spp
spp
ESBL
17
19
11
46
17
IPM
LVX
MEM
NIT
OFX
PEN
TOB
SXT
ESBL
67
127
85
972
389
1
19
498
GEN
CIP
CHL
819
852
671
312
CXM
CXA
CRO
CAZ
CTX
CZO
ATM
20
17,7
28
34,1
37
28,2
29,2
34,6
32,3
45,5
48,7
50,6
40,6
36,6
26,5
60
849
764
838
702
836
23
709
SAM
AMP
40
329
0
63,9
69,6
76,8
80
AMC
87,5
100
98,2
100
531
120
100
83,3
80
100
87,5
100
120
ESBL
SXT
TOB
0
5
PEN
OFX
8
MEM
1
LVX
3
0
IPM
14
GEN
9
CIP
16
59
CHL
51
CXM
34
CXA
43
CRO
1
CAZ
63
CTX
64
63
ATM
SAM
51
AMP
18
15
AMC
7,1
20
0
33,3
30,6
43,1
44,4
60,5
58,1
25
40
44,1
38,7
60
48,8
58,1
80
96
90,2
46
0
20
17,4
26,7
20,9
27,6
CXA
23
25,5
CRO
CTX
356
24,8
33,4
CZO
718
CAZ
34,4
ATM
23,2
40
60
38,9
48,9
60,8
76,4
100
80
100
120
383
ESBL
SXT
2
TOB
311
NIT
15
OFX
MEM
54
841
LVX
411
GEN
425
CIP
396
CHL
721
385
452
SAM
392
AMP
204
296
AMC
100
120
45,5
53,8
37,5
19,8
39,3
CXA
31,9
40,5
CRO
40
28,8
39,2
CAZ
50
33,8
45
57,6
71
81,1
60
CTX
80
76
100
20
62
ESBL
SXT
OFX
NIT
MEM
8 131 55 1
TOB
50 37 71 1 118 60 74 74 122 66 66 72 13
LVX
GEN
CIP
CHL
CZO
ATM
SAM
AMP
AMC
100
0
25
34,3
51,8
97,7
0
22,9
20,7
48,2
306
16,4
50
20
326
15,8
22,6
33,3
34,4
40
23,3
30,8
60
24,1
55,7
52
80
69,2
100
100
98,1
120
100
120
220
131
35
87
220
12
61
190
152
31
15
340
103
39
107
100
92,9
100
120
80
100
29,8
43,3
17
25
40
42
88
47
35
0
TOB
GEN
CIP
88
PIP
90
MEM
39
IPM
CRO
CAZ
CTX
ATM
20
ESBL
60
50
80
120
100
100
76,5
80
68,4
60
76,5
65,9
51,6
51,1
45,7
45,5
50
36,4
40
16,7
20
33
17
11
ESBL
GEN
17
TOB
45
OFX
CIP
CRO
CAZ
58
MEM
31
IPM
CTX
ATM
SAM
35
SXT
: -
3
:
,
,
,
,
.
.
.
, , ,
.
.
,
.
.
.
.
,
,
,
,
.
1 2
.
24
.
, 3-5
(Stop order )
.
,
,
.
: , ,
: 1
.
:
.
:
48 ,
:
: ,
.
.
(
)
,
,
-
.
,
:
,
,
, ,
:
:
,
,
. :
/(
)
,
,
,
,
3
- ;
,
.
-
-
/
, , :
, ,
,
,
.
,
,
,
,
, ,
,
.
,
,
.
,
.
,
,
.
48
:
?
,
,
?
(de-escalation)?
?
-
, ,
.
Pharmacy-driven Interventions
:
/ ,
-, ./
.
:
/ ./
:
Automatic alerts in situations where therapy might be
unnecessarily duplicative including simultaneous use of
multiple agents with overlapping spectra e.g. anaerobic
activity, atypical activity, Gram-negative activity and
resistant Gram-positive activity
:
. / ,
./
:
.
-
,
: /
.
.
Skin and soft tissue infections
- Staphylococcus
aureus (MRSA)
Clostridium difficile .
,
.
/
,
,
,
,
.
http://www.cdc.gov/getsmart/healthcare/pdfs/chec
klist.pdf
.
.
,
.
,
./ ./
.
.
/ 2
/ .
.
.
, ,
,
,
.
.
.
.
,
.
. : :
, PNA FISH , MALDI-TOF ,
.
.
.
,
,
3
, ,
:
,